A relatively high number of pregnant women in kuwait remain susceptible to rubella: A need for an alternative vaccination policy

Medical Principles and Practice

Volumn 23, Issue 2, 2014, Pages 145-148

  Madi, Nada ^a   Al Tawalah, Haya ^a   Abdul Khalik, Dina ^a   Al Nakib, Widad ^a  

^a KUWAIT UNIVERSITY   (Kuwait)

Author keywords

Hepatitis B; Kuwait; Pregnant women; Rubella

Indexed keywords

HEPATITIS B SURFACE ANTIGEN; IMMUNOGLOBULIN G ANTIBODY; RUBELLA ANTIBODY; RUBELLA VACCINE;

ADOLESCENT; ADULT; ANTIBODY BLOOD LEVEL; ANTIBODY DETECTION; ANTIBODY TITER; ANTIGEN DETECTION; ARTICLE; FEMALE; GROUPS BY AGE; HEALTH CARE POLICY; HEPATITIS B; HIGH RISK POPULATION; HUMAN; INFECTION SENSITIVITY; KUWAIT; MAJOR CLINICAL STUDY; PREGNANT WOMAN; PREVALENCE; RETROSPECTIVE STUDY; RUBELLA; VACCINATION; HEALTH CENTER; LABORATORY TEST; MEDICAL RECORD REVIEW; PROGRAM EFFECTIVENESS; SCREENING; SUSCEPTIBLE POPULATION; YOUNG ADULT;

ADOLESCENT; ADULT; AGE FACTORS; FEMALE; HEALTH POLICY; HEPATITIS B SURFACE ANTIGENS; HUMANS; IMMUNOGLOBULIN G; KUWAIT; MIDDLE AGED; PREGNANCY; PREVALENCE; RETROSPECTIVE STUDIES; RUBELLA; RUBELLA VACCINE; YOUNG ADULT;

EID: 84896126356     PISSN: 10117571     EISSN: 14230151     Source Type: Journal    
DOI: 10.1159/000356892     Document Type: Article

References (23)

1. Hamdan HZ, Abdelbagi IE, Nasser NM, et al: Seroprevalence of cytomegalovirus and rubella among pregnant women in western Sudan. Virol J 2011; 11: 8:217.
2. Calimeri S, Capua A, La Fauci V, et al: Prevalence of serum anti-rubella virus antibodies among pregnant women in southern Italy. Int J Gynaecol Obstet 2012; 116: 211-213.
3. Uyar Y, Balci A, Akcali A, et al: Prevalence of rubella and cytomegalovirus antibodies among pregnant women in northern Turkey. New Microbiol 2008; 31: 451-455.
4. Cutts FT, Robertson SE, Diaz-Ortega JL, et al: Control of rubella and congenital rubella syndrome (CRS) in developing countries. 1. Burden of disease from CRS. Bull World Health Organ 1997; 75: 55-68. (Pubitemid 27204820)
5. Linguissi LS, Nagalo BM, Bisseye C, et al: Seroprevalence of toxoplasmosis and rubella in pregnant women attending antenatal private clinic at Ouagadougou, Burkina Faso. Asian Pac J Trop Med 2012; 5: 810-813.
6. Robertson SE, Featherstone DA, Gacic-Dobo M, et al: Rubella and congenital rubella syndrome: global update. Rev Panam Salud Publica 2003; 14: 306-315. (Pubitemid 38056800)
7. Montoya JG, Liesenfeld O: Toxoplasmosis. Lancet 2004; 363: 1965-1976. (Pubitemid 38759657)
8. Bertolini DA, Pinho JR, Saraceni CP, et al: Prevalence of serological markers of hepatitis B virus in pregnant women from Paraná State, Brazil. Braz J Med Biol Res 2006; 39: 1083-1090.
9. Zhang S, Li RT, Wang Y, et al: Seroprevalence of hepatitis B surface antigen among pregnant women in Jiangsu, China, 17 years after introduction of hepatitis B vaccine. Int J Gynaecol Obstet 2010; 109: 194-197.
10. Hyams KC: Risks of chronicity following acute hepatitis B virus infection: a review. Clin Infect Dis1995; 20: 992-1000.
11. Ganem D, Prince AM: Hepatitis B virus infection-natural history and clinical consequences. N Engl J Med 2004; 350: 1118-1129. (Pubitemid 38298992)
12. Salleras L, Domínguez A, Bruguera M, et al: Seroepidemiology of hepatitis B virus infection in pregnant women in Catalonia (Spain). J Clin Virol 2009; 44: 329-332.
13. Pol S, Corouge M, Fontaine H: Hepatitis B virus infection and pregnancy. Clin Res Hepatol Gastroenterol 2011; 35: 618-622.
14. Bracciale L, Fabbiani M, Sansoni A, et al: Impact of hepatitis B vaccination in children born to HBsAg-positive mothers: a 20-year retrospective study. Infection 2009; 37: 340-343.
15. Mehta NM, Thomas RM: Antenatal screening for rubella-infection or immunity BMJ 2002; 13; 325: 90-91.
16. Aksakal FN, Maral I, Cirak MY, et al: Rubella seroprevalence among women of childbearing age residing in a rural region: is there a need for rubella vaccination in Turkey Jpn J Infect Dis 2007; 60: 157-160. (Pubitemid 47365030)
17. Sathanandan D, Gupta L, Liu B, et al: Factors associated with low immunity to rubella infection on antenatal screening. Aust NZ J Obstet Gynaecol 2005; 45: 435-438. (Pubitemid 41830369)
18. Bukbuk DN, el Nafaty AU, Obed JY: Prevalence of rubella-specific IgG antibody in nonimmunized pregnant women in Maiduguri, north eastern Nigeria. Cent Eur J Public Health 2002; 10: 21-23. (Pubitemid 34663948)
19. Palihawadana P, Wickremasinghe AR, Perera J: Seroprevalence of rubella antibodies among pregnant females in Sri Lanka. Southeast Asian J Trop Med Public Health 2003; 34: 398-404. (Pubitemid 37141278)
20. Odland J∅, Sergejeva IV, Ivaneev MD, et al: Seropositivity of cytomegalovirus, parvovirus and rubella in pregnant women and recurrent aborters in Leningrad County, Russia. Acta Obstet Gynecol Scand 2001; 80: 1025-1029. (Pubitemid 33054106)
21. Hathout H, Al-Nakib W, Lilley H, et al: Seroepidemiology of rubella in Kuwait: an alternative vaccination policy. Int J Epidemiol1978; 7: 49-53. (Pubitemid 8328481)
22. Makhseed M, Moussa MA, Ahmed MA, et al: The status of rubella immunity among pregnant women in Kuwait: screening in childbearing age should be reintroduced. Acta Trop 2001; 78: 35-40. (Pubitemid 32115464)
23. Nordenfelt E, Al-Nakib W, Atack W, et al: The recent rubella epidemic in Kuwait: analysis of laboratory data and further preventive measures. J Kuwait Med Assoc 1984; 18: 67-73.